US intergroup anal carcinoma trial: Tumor diameter predicts for colostomy

Journal of Clinical Oncology

Volumn 27, Issue 7, 2009, Pages 1116-1121

  Ajani, Jaffer A ^a   Winter, Kathryn A ^a   Gunderson, Leonard L ^a   Pedersen, John ^a   Benson Iii, Al B ^a   Thomas Jr, Charles R ^a   Mayer, Robert J ^a   Haddock, Michael G ^a   Rich, Tyvin A ^a   Willett, Christopher G ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN;

ADULT; ANUS CARCINOMA; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLOSTOMY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TUMOR VOLUME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CISPLATIN; COLOSTOMY; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; MALE; MITOMYCIN; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 61449252531     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.6857     Document Type: Article

References (15)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58:71-96, 2008
2. Nigro ND, Seydel HG, Considine B, et al: Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 51:1826-1829, 1983
3. Sischy B, Doggett RL, Krall JM, et al: Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: Interim report on Radiation Therapy Oncology Group study no. 8314. J Natl Cancer Inst 81:850-856, 1989
4. Nilsson PJ, Svensson C, Goldman S, et al: Epidermoid anal cancer: A review of a population-based series of 308 consecutive patients treated according to prospective protocols. Int J Radiat Oncol Biol Phys 61:92-102, 2005
5. Svensson C, Goldman S, Friberg B: Radiation treatment of epidermoid cancer of the anus. Int J Radiat Oncol Biol Phys 27:67-73, 1993
6. Ajani JA, Winter KA, Gunderson LL, et al: Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cispla- tin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial. JAMA 209:23-30, 2008
7. Fuchshuber PR, Rodriguez-Bigas M, Petrelli N: Anal canal and perianal epidermoid cancer. J Am Coll Surg 185:494-505, 1997
8. Das P, Crane CH, Ajani JA: Current treatment for localized anal carcinoma. Curr Opin Oncol 19: 396-400, 2007
9. Flam M, John M, Pajak TF, et al: Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 14:2527-2539, 1996
10. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
11. Mantel N: Evaluation of survival data and two new rank order statistics arising in ints consideration. Cancer Chemother Rep 50:163-170, 1966
12. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, John Wiley & Sons, 1980
13. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
14. Saarilahti K, Arponen P, Vaalavirta L, et al: The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following che moradiotherapy of anal cancer. Radiother Oncol 87:383-390, 2008
15. Ang KK, Harris J, Garden AS, et al: Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: Radiation therapy oncology group phase II trial 99-14. J Clin Oncol 23:3008-3015, 2005